These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26702847)

  • 41. Oxyntomodulin : a novel potential treatment for obesity.
    Druce MR; Bloom SR
    Treat Endocrinol; 2006; 5(5):265-72. PubMed ID: 17002486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut peptides in the regulation of food intake and energy homeostasis.
    Murphy KG; Dhillo WS; Bloom SR
    Endocr Rev; 2006 Dec; 27(7):719-27. PubMed ID: 17077190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gastrointestinal Peptides as Therapeutic Targets to Mitigate Obesity and Metabolic Syndrome.
    Alexiadou K; Tan TM
    Curr Diab Rep; 2020 May; 20(7):26. PubMed ID: 32436022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.
    Field BC; Wren AM; Peters V; Baynes KC; Martin NM; Patterson M; Alsaraf S; Amber V; Wynne K; Ghatei MA; Bloom SR
    Diabetes; 2010 Jul; 59(7):1635-9. PubMed ID: 20357366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism.
    Perez-Tilve D; Nogueiras R; Mallo F; Benoit SC; Tschoep M
    Endocrine; 2006 Feb; 29(1):61-71. PubMed ID: 16622293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 years.
    Rose F; Bloom S; Tan T
    Expert Opin Drug Discov; 2019 Nov; 14(11):1151-1159. PubMed ID: 31355685
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of bariatric surgery on gut hormones that alter appetite.
    Pournaras DJ; Le Roux CW
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):508-12. PubMed ID: 20152735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut hormones as potential new targets for appetite regulation and the treatment of obesity.
    Field BC; Wren AM; Cooke D; Bloom SR
    Drugs; 2008; 68(2):147-63. PubMed ID: 18197723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut hormones and reproduction.
    Izzi-Engbeaya C; Dhillo WS
    Ann Endocrinol (Paris); 2022 Aug; 83(4):254-257. PubMed ID: 35750201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging therapies in the treatment of 'diabesity': beyond GLP-1.
    Tharakan G; Tan T; Bloom S
    Trends Pharmacol Sci; 2011 Jan; 32(1):8-15. PubMed ID: 21130506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery.
    Karra E; Yousseif A; Batterham RL
    Trends Endocrinol Metab; 2010 Jun; 21(6):337-44. PubMed ID: 20133150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.
    Pocai A; Carrington PE; Adams JR; Wright M; Eiermann G; Zhu L; Du X; Petrov A; Lassman ME; Jiang G; Liu F; Miller C; Tota LM; Zhou G; Zhang X; Sountis MM; Santoprete A; Capito' E; Chicchi GG; Thornberry N; Bianchi E; Pessi A; Marsh DJ; SinhaRoy R
    Diabetes; 2009 Oct; 58(10):2258-66. PubMed ID: 19602537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DPP-IV-resistant, long-acting oxyntomodulin derivatives.
    Santoprete A; Capitò E; Carrington PE; Pocai A; Finotto M; Langella A; Ingallinella P; Zytko K; Bufali S; Cianetti S; Veneziano M; Bonelli F; Zhu L; Monteagudo E; Marsh DJ; Sinharoy R; Bianchi E; Pessi A
    J Pept Sci; 2011 Apr; 17(4):270-80. PubMed ID: 21294225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ontogeny and the effect of aging on pancreatic polypeptide and peptide YY.
    Sandström O; El-Salhy M
    Peptides; 2002 Feb; 23(2):263-7. PubMed ID: 11825641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs.
    Wewer Albrechtsen NJ; Kuhre RE; Toräng S; Holst JJ
    BMC Res Notes; 2016 Feb; 9():60. PubMed ID: 26830025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of gut hormones in appetite regulation (review).
    Marić G; Gazibara T; Zaletel I; Labudović Borović M; Tomanović N; Ćirić M; Puškaš N
    Acta Physiol Hung; 2014 Dec; 101(4):395-407. PubMed ID: 25532952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incretins, amylin and other gut-brain axis hormones in children with coeliac disease.
    Papastamataki M; Papassotiriou I; Bartzeliotou A; Vazeou A; Roma E; Chrousos GP; Kanaka-Gantenbein C
    Eur J Clin Invest; 2014 Jan; 44(1):74-82. PubMed ID: 24151959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptide YY 3-36 and pancreatic polypeptide differentially regulate hypothalamic neuronal activity in mice in vivo as measured by manganese-enhanced magnetic resonance imaging.
    Hankir MK; Parkinson JR; Minnion JS; Addison ML; Bloom SR; Bell JD
    J Neuroendocrinol; 2011 Apr; 23(4):371-80. PubMed ID: 21251093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postprandial changes in gut regulatory peptides in gastric bypass patients.
    Holdstock C; Zethelius B; Sundbom M; Karlsson FA; Edén Engström B
    Int J Obes (Lond); 2008 Nov; 32(11):1640-6. PubMed ID: 18794895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.